PMVP

PMV Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector with a market capitalization of $64.92 million. The company has 47 employees and operates within the biotechnology industry. The financial health of PMV Pharmaceuticals, Inc. indicates significant losses, with net income (TTM) totaling -$82,705,000 and EBITDA standing at -$91,396,000. Additionally, the company's free cash flow is -$48,136,376, which may indicate challenges in generating cash from its operations. The company's gross margin, operating margin, and profit margin are all 0.0%, suggesting a lack of profitability. PMV Pharmaceuticals, Inc.'s returns on equity (ROE) and return on assets (ROA) are negative at -51.9% and -32.0%, respectively, indicating poor earnings performance. The company's valuation metrics suggest a high level of pessimism among investors, with a forward P/E ratio of -0.85 and an EV/EBITDA ratio of 0.69. This contrasts with the price to book ratio of 0.53, which suggests some undervaluation. The current ratio is 10.77, indicating a high level of liquidity.